Concepedia

Sridharan Rajagopal

SR

23

Publications

1.3K

Citations

17

H-Index

1997

Active since

Affiliations

Jubilant Life Sciences (India)(Current)

Sanofi (Germany)

Miami University

Orchid Pharma (India)

Harvard University

Sridharan Rajagopal is an author at Jubilant Life Sciences (India) specializing in pharmacology, medicine, and drug discovery.

ORCID

Top concepts

Publications per year

1997–2023

23

Publications

23

Journal of Molecular Catalysis A Chemical 332 (2010) 128–137

Pitchaimani Veerakumar, Zong‐Zhan Lu, Murugesan Velayudham et al. · 2015 · 552 citations

, , +1

A small molecule inhibitor of Nicotinamide N-methyltransferase for the treatment of metabolic disorders

Aimo Kannt, Sridharan Rajagopal, Sanjay Venkatachalapathi Kadnur et al. · Scientific Reports · 2018 · 96 citations · Full text

A Novel Selective Inhibitor JBI-589 Targets PAD4-Mediated Neutrophil Migration to Suppress Tumor Progression

Hui Deng, Cindy Lin, Laura Garcia-Gerique et al. · Cancer Research · 2022 · 71 citations · Full text

Alleviation of arthritis through prevention of neutrophil extracellular traps by an orally available inhibitor of protein arginine deiminase 4

Chandru Gajendran, Shoichi Fukui, Naveen M. Sadhu et al. · Scientific Reports · 2023 · 58 citations · Full text

An improved method of transcutaneous cisterna magna puncture for cerebrospinal fluid sampling in rats

Mahamad Yunnus A. Mahat, N. Fakrudeen Ali Ahamed, S. Chandrasekaran et al. · Journal of Neuroscience Methods · 2012 · 50 citations

,

Rows per page

1–5 of 23